MeSH D008052 - inborn errors lipid metabolism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006938:Hyperlipoproteinemia type ii
D006950:Familial combined hyperlipidemia
D006952:Hyperlipoproteinemia type iii
0 Companies
0 Drugs
Success rate
D006953:Hyperlipoproteinemia type iv
0 Companies
0 Drugs
Success rate
D006954:Hyperlipoproteinemia type v
0 Companies
0 Drugs
Success rate
D007009:Hypolipoproteinemias
0 Companies
0 Drugs
Success rate
D008064:Lipidoses
0 Companies
0 Drugs
Success rate
D008072:Hyperlipoproteinemia type i
D019082:Smith-lemli-opitz syndrome
0 Companies
0 Drugs
Success rate
D052497:Congenital generalized lipodystrophy
0 Companies
0 Drugs
Success rate
D056889:Barth syndrome
0 Companies
0 Drugs
Success rate
D000081003:Shwachman-diamond syndrome
0 Companies
0 Drugs
Success rate
D052476:Familial hypobetalipoproteinemia apolipoprotein b
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
33%1/3
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use